These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
191 related items for PubMed ID: 8120139
21. Role of antigen-presenting cells in the polarized development of helper T cell subsets: evidence for differential cytokine production by Th0 cells in response to antigen presentation by B cells and macrophages. Duncan DD, Swain SL. Eur J Immunol; 1994 Oct; 24(10):2506-14. PubMed ID: 7925578 [Abstract] [Full Text] [Related]
22. Induction of interferon-gamma, interleukin-4, and transforming growth factor-beta in rats orally tolerized against experimental autoimmune myasthenia gravis. Wang ZY, Link H, Ljungdahl A, Höjeberg B, Link J, He B, Qiao J, Melms A, Olsson T. Cell Immunol; 1994 Sep; 157(2):353-68. PubMed ID: 7520837 [Abstract] [Full Text] [Related]
23. The effect of thymectomy on autoreactive T- and B-lymphocytes in myasthenia gravis. Ahlberg R, Yi Q, Pirskanen R, Matell G, Sundevall AC, Aberg B, Lefvert AK. J Neuroimmunol; 1997 Apr; 74(1-2):45-54. PubMed ID: 9119978 [Abstract] [Full Text] [Related]
24. Intrathymic Tfh/B Cells Interaction Leads to Ectopic GCs Formation and Anti-AChR Antibody Production: Central Role in Triggering MG Occurrence. Zhang X, Liu S, Chang T, Xu J, Zhang C, Tian F, Sun Y, Song C, Yi W, Lin H, Li Z, Yang K. Mol Neurobiol; 2016 Jan; 53(1):120-131. PubMed ID: 25407929 [Abstract] [Full Text] [Related]
25. Mucosal tolerance to experimental autoimmune myasthenia gravis is associated with down-regulation of AChR-specific IFN-gamma-expressing Th1-like cells and up-regulation of TGF-beta mRNA in mononuclear cells. Ma CG, Zhang GX, Xiao BG, Wang ZY, Link J, Olsson T, Link H. Ann N Y Acad Sci; 1996 Feb 13; 778():273-87. PubMed ID: 8610980 [Abstract] [Full Text] [Related]
27. The effect of B cell deficiency on the immune response to acetylcholine receptor and the development of experimental autoimmune myasthenia gravis. Dedhia V, Goluszko E, Wu B, Deng C, Christadoss P. Clin Immunol Immunopathol; 1998 Jun 13; 87(3):266-75. PubMed ID: 9646836 [Abstract] [Full Text] [Related]
28. Autoimmune human T lymphocytes specific for acetylcholine receptor. Hohlfeld R, Toyka KV, Heininger K, Grosse-Wilde H, Kalies I. Nature; 1998 Jun 13; 310(5974):244-6. PubMed ID: 6611507 [Abstract] [Full Text] [Related]
29. Effects of Follicular Helper T Cells and Inflammatory Cytokines on Myasthenia Gravis. Wang L, Zhang Y, Zhu M, Feng J, Han J, Zhu J, Deng H. Curr Mol Med; 2019 Jun 13; 19(10):739-745. PubMed ID: 31453784 [Abstract] [Full Text] [Related]
30. Phenotypic and functional characterization of T cells from patients with myasthenia gravis. Mokhtarian F, Pino M, Ofosu-Appiah W, Grob D. J Clin Invest; 1990 Dec 13; 86(6):2099-108. PubMed ID: 1979338 [Abstract] [Full Text] [Related]
31. Absence of IFN-gamma or IL-12 has different effects on experimental myasthenia gravis in C57BL/6 mice. Karachunski PI, Ostlie NS, Monfardini C, Conti-Fine BM. J Immunol; 2000 May 15; 164(10):5236-44. PubMed ID: 10799884 [Abstract] [Full Text] [Related]
32. Anti-AChR antibodies, thymic histology, and T cell subsets in myasthenia gravis. Berrih S, Morel E, Gaud C, Raimond F, Le Brigand H, Bach JF. Neurology; 1984 Jan 15; 34(1):66-71. PubMed ID: 6228745 [Abstract] [Full Text] [Related]
33. The limitation of IL-10-exposed dendritic cells in the treatment of experimental autoimmune myasthenia gravis and myasthenia gravis. Xiao BG, Duan RS, Zhu WH, Lu CZ. Cell Immunol; 2006 Jun 15; 241(2):95-101. PubMed ID: 17005165 [Abstract] [Full Text] [Related]
34. T-cell epitopes on the human acetylcholine receptor alpha-subunit residues 10-84 in myasthenia gravis. Ahlberg R, Yi Q, Eng H, Pirskanen R, Lefvert AK. Scand J Immunol; 1992 Sep 15; 36(3):435-42. PubMed ID: 1381519 [Abstract] [Full Text] [Related]
35. T-cell immunity to acetylcholine receptor and its subunits in Lewis rats over the course of experimental autoimmune myasthenia gravis. Wang ZY, Link H, Huang WX. Scand J Immunol; 1993 May 15; 37(5):615-22. PubMed ID: 7683442 [Abstract] [Full Text] [Related]
36. Transforming growth factor-beta 1 suppresses autoantigen-induced expression of pro-inflammatory cytokines but not of interleukin-10 in multiple sclerosis and myasthenia gravis. Link J, He B, Navikas V, Palasik W, Fredrikson S, Söderström M, Link H. J Neuroimmunol; 1995 Apr 15; 58(1):21-35. PubMed ID: 7537278 [Abstract] [Full Text] [Related]
37. Idiotypic and antiidiotypic T and B lymphocytes in myasthenia gravis. Yi Q, Lefvert AK. J Immunol; 1992 Nov 15; 149(10):3423-6. PubMed ID: 1431116 [Abstract] [Full Text] [Related]
38. Organ-specific autoantigens induce interferon-gamma and interleukin-4 mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis. Link J, Söderström M, Ljungdahl A, Höjeberg B, Olsson T, Xu Z, Fredrikson S, Wang ZY, Link H. Neurology; 1994 Apr 15; 44(4):728-34. PubMed ID: 7513071 [Abstract] [Full Text] [Related]
39. Transgenic expression of IL-10 in T cells facilitates development of experimental myasthenia gravis. Ostlie NS, Karachunski PI, Wang W, Monfardini C, Kronenberg M, Conti-Fine BM. J Immunol; 2001 Apr 15; 166(8):4853-62. PubMed ID: 11290761 [Abstract] [Full Text] [Related]
40. Exogenous IL-9 Ameliorates Experimental Autoimmune Myasthenia Gravis Symptoms in Rats. Yao X, Zhao J, Kong Q, Xie X, Wang J, Sun B, Xu L, Mu L, Li H. Immunol Invest; 2018 Oct 15; 47(7):712-724. PubMed ID: 29944018 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]